Back to Search
Start Over
Bimatoprost, prostamide activity, and conventional drainage.
- Source :
-
Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2007 Sep; Vol. 48 (9), pp. 4107-15. - Publication Year :
- 2007
-
Abstract
- Purpose: Despite structural similarity with prostaglandin F(2 alpha), the ocular hypotensive agent bimatoprost (Lumigan; Allergan, Inc., Irvine, CA) shows unique pharmacology in vitro and functional activity in vivo. Unfortunately, the precise mechanisms that underlie bimatoprost's distinctive impact on aqueous humor dynamics are unclear. The purpose of the present study was to investigate the effects of bimatoprost and a novel prostamide-selective antagonist AGN 211334 on human conventional drainage.<br />Methods: Two model systems were used to test the consequences of bimatoprost and/or AGN 211334 treatment on conventional drainage. Human anterior segments in organ culture were perfused at a constant flow rate of 2.5 microL/min while pressure was recorded continuously. After stable baseline facilities were established, segments were treated with drug(s), and pressure was monitored for an additional 3 days. In parallel, the drugs' effects on hydraulic conductivity of human trabecular meshwork (TM) cell monolayers were evaluated. Pharmacological properties of AGN 211334 were characterized in isolated feline iris preparations in organ culture and heterologously expressed G-protein-coupled receptors were examined in vitro.<br />Results: Bimatoprost increased outflow facility by an average of 40% +/- 10% within 48 hours of treatment (n = 10, P < 0.001). Preincubation or coincubation with AGN 211334 significantly blunted bimatoprost's effects by 95% or 43%, respectively. Similar results were obtained in cell culture experiments in which bimatoprost increased hydraulic conductivity of TM cell monolayers by 78% +/- 25%. Pretreatment with AGN 211334 completely blocked bimatoprost's effects, while coincubation decreased its effects on average by 74%. In both models, AGN 211334 alone significantly decreased fluid flux across trabecular tissues and cells.<br />Conclusions: The findings indicate that bimatoprost interacts with a prostamide receptor in the trabecular meshwork to increase outflow facility.
- Subjects :
- Aged
Aged, 80 and over
Amides antagonists & inhibitors
Animals
Aqueous Humor metabolism
Bimatoprost
Calcium metabolism
Calcium Signaling physiology
Cats
Cell Culture Techniques
Cloprostenol antagonists & inhibitors
Cloprostenol pharmacology
Dinoprost pharmacology
Dinoprostone analogs & derivatives
Dinoprostone pharmacology
Female
Humans
Intraocular Pressure physiology
Iris drug effects
Lipids antagonists & inhibitors
Male
Middle Aged
Muscle Contraction physiology
Muscle, Smooth drug effects
Organ Culture Techniques
Oxazoles pharmacology
Receptors, Thromboxane antagonists & inhibitors
Receptors, Thromboxane metabolism
Recombinant Proteins
Trabecular Meshwork metabolism
Amides pharmacology
Antihypertensive Agents pharmacology
Cloprostenol analogs & derivatives
Lipids pharmacology
Trabecular Meshwork drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 0146-0404
- Volume :
- 48
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Investigative ophthalmology & visual science
- Publication Type :
- Academic Journal
- Accession number :
- 17724194
- Full Text :
- https://doi.org/10.1167/iovs.07-0080